Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.200
+0.120 (3.90%)
At close: Oct 23, 2025, 4:00 PM EDT
3.199
-0.001 (-0.03%)
After-hours: Oct 23, 2025, 7:59 PM EDT
Clover Health Investments Revenue
Clover Health Investments had revenue of $477.62M in the quarter ending June 30, 2025, with 34.07% growth. This brings the company's revenue in the last twelve months to $1.61B, up 22.12% year-over-year. In the year 2024, Clover Health Investments had annual revenue of $1.37B with 8.52% growth.
Revenue (ttm)
$1.61B
Revenue Growth
+22.12%
P/S Ratio
1.00
Revenue / Employee
$2,820,877
Employees
570
Market Cap
1.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.37B | 107.61M | 8.52% |
| Dec 31, 2023 | 1.26B | 63.77M | 5.32% |
| Dec 31, 2022 | 1.20B | -162.08M | -11.91% |
| Dec 31, 2021 | 1.36B | 671.35M | 97.30% |
| Dec 31, 2020 | 690.02M | 235.27M | 51.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CLOV News
- 1 day ago - Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference - GlobeNewsWire
- 8 days ago - Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice - GlobeNewsWire
- 9 days ago - Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners - GlobeNewsWire
- 14 days ago - Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027 - GlobeNewsWire
- 16 days ago - Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025 - GlobeNewsWire
- 17 days ago - Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant - GlobeNewsWire
- 4 weeks ago - Counterpart Assistant Gets Conversational - GlobeNewsWire
- 5 weeks ago - Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries - GlobeNewsWire